Sabril effect on seizure control of children with refractory epilepsy

Effect of Sabril on seizure control of children with interactable epilepsy admitted to Mofid hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012091210508N3

Enrollment

Registered

2012-10-13

Start date

2011-10-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy. Episodic and paroxysmal disorders

Interventions

Sixty seven children with seizures which admitted to Mofid children hospital and despite taking two or three anti-seizure medication, have uncontrolled seizure and have no anticonvulsant sensitivity h

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children one to eighteen years ;having interactable epilepsy Exclusion criteria: anticonvulsant sensitivity

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Seizure. Timepoint: 1 and 6 months later. Method of measurement: Interview.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Kazem Bakhshandeh Bali

Pediatric neurology research center

Dr.MK.Bakhshandehbali@sbmu.ac.ir+212 2259625

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026